Given the hyperactivation of neddylation in RTECs and its potential role in DN, we employed an AAV9-packaged NAE1 knockdown plasmid to assess its therapeutic potential in diabetic mice. The gene discussed is NAE1; the disease is liver dysplastic nodule.